Fabian Prospective Assessment of Volume Guarantee (Fabian PaVoG)
NCT ID: NCT05229172
Last Updated: 2023-06-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
76 participants
OBSERVATIONAL
2022-02-24
2023-06-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Randomized, Multicenter Study of the Safety and Performance of Fabian PRICO for Saturation Targeting With Non-invasive Respiratory Support
NCT05823909
Safety Study of Non-invasive Ventilation Versus High-flow Oxygen in Patients With Hypoxemic Respiratory Failure Undergoing Fiberoptic Bronchoscopy.
NCT01870765
High Flow Ventilation With Volume Guarantee
NCT02571231
Mechanisms of Altered Ventilatory Control in Heart Failure
NCT02421341
Optimization of Ventilation Strategies in Preterm and Term Infants in a Single-center Intervention Study
NCT05512689
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study procedures will be conducted according to standard of care of each participating hospital and the instructions for use of the study device.
To allow data collection, an Informed Consent Form will be obtained from each study participant/ legally authorized representative, if required by the local Ethical Committee. Ventilator data will be recorded in the hospital's data capture system or on a study laptop provided by the Sponsor.
Each patient will be clinically evaluated according to hospital standard of care. If inclusion and exclusion criteria are met, and the investigative team is available the patient will be enrolled.
Study duration for an individual patient will differ, depending on the time spent on fabian ventilator with Volume Guarantee mode on.
It is anticipated that for most will be between 2-4 days.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Volume Targeted Ventilation
There is no study specific intervention planned. Procedures will be conducted according to standard of care of each participating hospital and the instructions for use of the study device.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The anticipated use of VG mode is at least 12 hours
* Informed Consent given by parents or guardians according to the process approved by the local research ethical committee
Exclusion Criteria
* Decision documented to give palliative neonatal care.
* The clinical care team does not agree with inclusion of the infant to the study
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vyaire Medical
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gusztav Belteki, MD, PhD
Role: STUDY_CHAIR
Cambridge University Hospitals NHS Trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Medical Center Amsterdam, The Netherlands
Amsterdam, , Netherlands
Szpital Położniczo - Ginekologiczny Ujastek
Krakow, , Poland
Ginekologiczno-Położniczy Szpital Kliniczny Uniwersytetu Medycznego im. Karola Marcinkowskiego
Poznan, , Poland
Centre of Postgraduate Medical Education, SPSK im prof.W.Orłowskiego
Warsaw, , Poland
John Radcliffe Hospital
Oxford, Oxfordshire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CS-21-003-PaVoG
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.